Stuart Osborne
Impact in
- Gastroenterology top 1%
- Gastrointestinal motility and disorders
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
Papers in
- Oncology 25
- Colorectal Cancer Treatments and Studies 12
- HER2/EGFR in Cancer Research 7
- Cancer Treatment and Pharmacology 6
-
- Lung Cancer Treatments and Mutations 7
- Co-authors
- István Láng (4 shared papers)David Cunningham (4 shared papers)Daniel Waterkamp (5 shared papers)Derek J. Jonker (4 shared papers)Mark Saunders (4 shared papers)Janja Ocvirk (4 shared papers)Dong Bok Shin (1 shared paper)Vito Lorusso (2 shared papers)
- Journals
- Annals of Oncology (11 papers)Journal of Clinical Oncology (6 papers)The Journal of Clinical Pharmacology (4 papers)Gastroenterology (3 papers)Blood (2 papers)
- Partner nations
- SwitzerlandFranceGermany
In The Last Decade
Stuart Osborne
56 papers receiving 1.7k citations
Stuart Osborne's Hit Papers
Peers
Comparison fields: 5 of 93
- Gastroenterology 309
- Oncology 808
- Genetics 191
- Pathology and Forensic Medicine 225
- Hepatology 92
Countries citing papers authored by Stuart Osborne
This map shows the geographic impact of Stuart Osborne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart Osborne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart Osborne more than expected).
Fields of papers citing papers by Stuart Osborne
This network shows the impact of papers produced by Stuart Osborne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart Osborne. The network helps show where Stuart Osborne may publish in the future.
Co-authors
The 25 scholars most cited alongside Stuart Osborne, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial Hit paper breakdown → | 2013 | 453 |
| 2 | 2001 | 187 | |
| 3 | 2013 | 180 | |
| 4 | 2018 | 116 | |
| 5 | 2016 | 107 | |
| 6 | 1999 | 89 | |
| 7 | 2017 | 56 | |
| 8 | 2018 | 55 | |
| 9 | 2017 | 43 | |
| 10 | 2016 | 36 | |
| 11 | 1999 | 31 | |
| 12 | 2021 | 30 | |
| 13 | 2006 | 28 | |
| 14 | 2015 | 25 | |
| 15 | 2013 | 25 | |
| 16 | 2023 | 25 | |
| 17 | 2013 | 23 | |
| 18 | 2001 | 23 | |
| 19 | 2001 | 19 | |
| 20 | 2017 | 17 |
About Stuart Osborne
Stuart Osborne is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Genetics and Radiology, Nuclear Medicine and Imaging, having authored 56 papers that have together received 1.8k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (12 papers), HER2/EGFR in Cancer Research (7 papers), Lymphoma Diagnosis and Treatment (7 papers), Lung Cancer Treatments and Mutations (7 papers), Cancer Treatment and Pharmacology (6 papers), Cancer Genomics and Diagnostics (4 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Gastrointestinal motility and disorders (3 papers). The work is most often cited by research in Gastroenterology (309 citations), Oncology (808 citations), Genetics (191 citations), Pathology and Forensic Medicine (225 citations) and Hepatology (92 citations). Stuart Osborne has collaborated with scholars based in Switzerland, France and Germany. Frequent co-authors include István Láng, David Cunningham, Daniel Waterkamp, Derek J. Jonker, Mark Saunders, Janja Ocvirk, Dong Bok Shin, Vito Lorusso, Eugenio Marcuello and Silke Appel‐Dingemanse. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, The Journal of Clinical Pharmacology, Gastroenterology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.